- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ACLARION Aktie jetzt für 0€ handeln | |||||
| 07.07. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.07. | Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
| 25.06. | Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery | - | RTTNews | ||
| 25.06. | Aclarion, Inc.: First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial | 3 | GlobeNewswire (USA) | ||
| 24.06. | Aclarion, Inc.: Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum | 1 | GlobeNewswire (USA) | ||
| 20.06. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | Aclarion, Inc.: Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 30.05. | Aclarion stock price target cut to $20 at Ascendiant Capital | 2 | Investing.com | ||
| 30.05. | Kursziel für Aclarion-Aktie von Ascendiant Capital auf 20 US-Dollar gesenkt | 1 | Investing.com Deutsch | ||
| 26.05. | XFRA NEW INSTRUMENTS AVAILABLE ON 26.05.2025 | 469 | Xetra Newsboard | The following instruments on XETRA do have their first trading 26.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.05.2025
Aktien
1 MXCFFM010000 Banco Invex S.A.
2... ► Artikel lesen | |
| 20.05. | Aclarion, Inc.: Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site | 9 | GlobeNewswire (USA) | ||
| 15.05. | Aclarion, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.05. | Aclarion, Inc.: Aclarion Announces Texas Back Institute as New CLARITY Trial Site | 1 | GlobeNewswire (USA) | ||
| 05.05. | Aclarion, Inc.: Aclarion Welcomes Advocate Health as CLARITY Trial Site | 2 | GlobeNewswire (USA) | ||
| 29.04. | Aclarion, Inc.: Aclarion Announces Commercial Agreement with Spine Institute of Louisiana | 4 | GlobeNewswire (USA) | ||
| 23.04. | Aclarion, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Aclarion, Inc.: Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 | 2 | GlobeNewswire (USA) | ||
| 21.04. | Aclarion, Inc.: Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis | 2 | GlobeNewswire (USA) | ||
| 09.04. | Aclarion, Inc.: Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub | 1 | GlobeNewswire (USA) | ||
| 09.04. | Aclarion, Inc. - 10-K, Annual Report | - | SEC Filings |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 444,50 | -0,37 % | Intuitive Surgical, Inc.: Intuitive demonstrates telesurgery capabilities | SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated... ► Artikel lesen | |
| UNITEDHEALTH | 242,95 | -0,10 % | Bank-Bilanzen im Fokus - Bitcoin, Nel, United Health, ASML, Goldman Sachs, BoA, Johnson & Johnson | Die Wall Street beendete den gestrigen Handelstag uneinheitlich. Während Standardwerte kaum gefragt waren, sorgte erneut der Technologiebereich für Bewegung. Der Nasdaq 100 stieg zur Eröffnung auf ein... ► Artikel lesen | |
| ROKU | 80,20 | -0,09 % | Roku Set For Q2 Spotlight As Ad Resilience, Frndly Boost, Amazon Deal Fuel Investor Optimism | ||
| SERNOVA BIOTHERAPEUTICS | 0,108 | +4,85 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,740 | +2,21 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,046 | -1,46 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,216 | +4,85 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CENTENE | 24,060 | +0,06 % | Centene-Aktie verliert 4,01 Prozent (25,1966 €) | Am US-amerikanischen Aktienmarkt liegt der Anteilsschein von Centene gegenwärtig im Minus. Der jüngste Kurs betrug 29,19 US-Dollar. An der Börse liegt der Anteilsschein von Centene derzeit im Minus.... ► Artikel lesen | |
| CYTOSORBENTS | 0,921 | +4,42 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,510 | -1,07 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| QUIDELORTHO | 23,000 | +4,55 % | RBC Capital Maintains a Buy Rating on QuidelOrtho Corporation (QDEL), Sets a $60 PT | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
| FRESENIUS | 40,890 | -0,87 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,110 | -1,03 % | BASF schraubt Erwartungen zurück, Brenntag wird ebenfalls vorsichtiger, Covestro reiht sich ein und Siemens Healthineers leidet unter Zollsorgen | Einmal mehr sorgt US-Präsident Donald Trump mit diversen Zolldrohungen für Verunsicherung an der Börse. Der EU werden ab August pauschal 30 Prozent für sämtliche Exporte in die USA in Aussicht gestellt... ► Artikel lesen |
ACLARION INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,020 (+0,32 %) liegt der Kurs bei 6,180 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACLARION INC finden Sie auf Wallstreet Online.